Impact of stearic acid and oleic acid on hemostatic factors in the context of controlled diets consumed by healthy men

Eur J Clin Nutr. 2014 Sep;68(9):1072-4. doi: 10.1038/ejcn.2014.62. Epub 2014 Apr 16.

Abstract

The effects of stearic acid (STA) on cardiovascular disease risk beyond lipid and lipoprotein risk factors, including hemostasis, are unclear, particularly when compared with unsaturated fatty acids. The aim of the present study is to compare the effects of STA with those of oleic acid (OL) on markers of hemostasis. In a randomized crossover study, 50 men consumed six controlled diets for 5 weeks each (39% energy from fat, 15% energy from protein, 46% energy from carbohydrate (CHO)). Fat (8% energy) was replaced across diets by: STA, OL, CHO (control), trans fatty acids (TFAs), TFA/STA and 12:0-16:0 saturated fatty acids. Factor VIIc, plasminogen activator inhibitor-1 (PAI-1) and plasmin alpha-2-antiplasmin complex concentrations were not different between OL and STA (P>0.05). Compared with control, OL increased factor VIIc and PAI-1 (P≤0.05), whereas there were no differences with STA (P>0.05). STA and OL similarly affect markers of hemostasis in healthy men, within the context of a highly controlled diet.

Publication types

  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Blood Coagulation Factors / metabolism*
  • Cross-Over Studies
  • Diet*
  • Dietary Fats / pharmacology*
  • Energy Intake
  • Factor VII / metabolism
  • Fibrinolysin / metabolism*
  • Hemostasis*
  • Humans
  • Male
  • Middle Aged
  • Oleic Acid / pharmacology*
  • Plasminogen Activator Inhibitor 1 / blood
  • Reference Values
  • Stearic Acids / pharmacology*
  • alpha-2-Antiplasmin / metabolism*

Substances

  • Blood Coagulation Factors
  • Dietary Fats
  • Plasminogen Activator Inhibitor 1
  • Stearic Acids
  • alpha-2-Antiplasmin
  • plasmin-plasmin inhibitor complex
  • Oleic Acid
  • stearic acid
  • Factor VII
  • Fibrinolysin